GlaxoSmithKline will update US labelling for its diabetes treatment Avandia to state there is no conclusive evidence linking it to …
NICE has rejected Schering-Plough's Remicade as a treatment for the debilitating form of spinal inflammation known as ankylosing spondylitis.The Institute …
Merck looks set to pay $4.9 billion in a settlement for the thousands of people claiming injury after taking its …
Acambis has struck a deal with Sanofi Pasteur to co-develop and co-market a vaccine for West Nile disease, a serious …
New research has been undertaken to help more women reach senior roles in the pharmaceutical industry. The study, carried out …
BioView and Transgenomic sign distribution agreement BioView has licensed Transgenomic to distribute its family of scanning and analysis workstations in …
A drug used to prevent excessive blood loss during surgery could be causing deaths in patients, and has been suspended …
The European launch of new diabetes drug Galvus could be delayed by up to six months after small but significant …
The Conservative party says the NHS must be freed from 'political tinkering' in order for it to focus on improving …
The role of pharmacists as frontline NHS clinicians is being promoted by the work of a key committee. The government …
A key target to cut waiting times for operations looks unlikely to be hit by the NHS, prompting the government …
AstraZeneca could face a major blow to its revenues if a generic challenger to Crestor is launched. The cholesterol lowering …
Efforts to cut unnecessary delays to UK clinical trials have taken a step forward with a new agreement to help …
Sanofi-Aventis outperformed expectations in the third quarter, after a strong performance from its vaccines business and the recovery of blockbuster …
NICE has rejected Orenica, a new treatment for rheumatoid arthritis, saying the drug is not a cost effective option for …
Third quarter figures show Roche's top-selling products have all posted double-digit advances on the same period in 2006. Growth for …